Table 5.
Clinical Acceptability Appraisal: Summary of Panel Judgments Regarding Guideline Perceived Comprehensiveness and Perceived Validity for 16 Selected Topics, Any Residual Guideline Content Aside from Those 16 Topics, and Overall
| AAOS | ACOEM | Intracorp | McK | ODG | |
|---|---|---|---|---|---|
| Perceived comprehensiveness of 16 topics, fraction (%) | |||||
| Not comprehensive | |||||
| All 16 topics | 11/16 (69) | 4/16 (25) | 0/16 (0) | 2/16 (13) | 2/16 (13) |
| Intermediate | |||||
| All 16 topics | 2/16 (25) | 6/16 (38) | 5/16 (31) | 6/16 (38) | 6/16 (38) |
| Topics covered* | 2/5 (40) | 6/12 (50) | 5/16 (31) | 6/14 (43) | 6/14 (43) |
| Comprehensive | |||||
| All 16 topics | 3/16 (19) | 6/16 (38) | 11/16 (69) | 8/16 (50) | 8/16 (50) |
| Topics covered* | 3/5 (60) | 6/12 (50) | 11/16 (69) | 8/14 (57) | 8/14 (57) |
| Residual content | Not comprehensive | Comprehensive | Intermediate | Intermediate | Intermediate |
| Overall | Intermediate | Intermediate | Intermediate | Intermediate | Intermediate |
| Perceived validity of topics covered, fraction (%) | |||||
| Not valid | |||||
| Topics covered* | 0/5 (0) | 0/12 (0) | 5/16 (31) | 0/14 (0) | 0/14 (0) |
| Uncertain | |||||
| Topics covered* | 3/5 (60) | 6/12 (50) | 10/16 (63) | 8/14 (57) | 9/14 (64) |
| Valid | |||||
| Topics covered* | 2/5 (40) | 6/12 (50) | 1/16 (6) | 6/14 (43) | 5/14 (36) |
| Residual content | N/A | Uncertain | Uncertain | Uncertain | Uncertain |
| Overall | Valid | Valid | Not Valid | Uncertain | Uncertain |
*Excludes topics that were judged not comprehensive on the assumption that the guideline was not intended to cover those topics. For example, if 11 of 16 guidelines were judged “not comprehensive” then the guideline covered 5 of the 16 topics and only those 5 topics are included in this denominator.